Recro Pharma, Inc. REPH
Set alert
2.09 +2.09 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 177.42M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -11.61
- Beta
- 0.00
- Short ratio
- 5.87
- Inst. own
- 54.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 5, 2022
- 50-d avg
- 1.73
- 200-d avg
- 1.88
- 1y target
- 5.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 5.00 +139.2% upside
Now 2.09
- Target (low)
- 4.00
- Target (mean)
- 5.00
- Target (high)
- 6.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09 | -0.10 – -0.08 | -0.23 | +60.9% | 19.42M | +15.6% | 3 |
| Next quarter | -0.03 | -0.04 – -0.02 | 0.03 | -200.0% | 25.05M | +39.0% | 3 |
| Current year | -0.22 | -0.23 – -0.20 | -0.26 | +15.4% | 92.12M | +22.2% | 3 |
| Next year | -0.18 | -0.22 – -0.14 | -0.22 | +18.2% | 99.90M | +8.4% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2021 | William Blair | Initiated | — | Outperform |
| May 12, 2020 | Oppenheimer | Maintained | — | Outperform |
| Mar 5, 2020 | Stephens & Co. | Maintained | — | Overweight |
| Nov 26, 2019 | Stephens & Co. | Maintained | — | Overweight |
| Oct 17, 2019 | Stephens & Co. | Initiated | — | Overweight |
| Mar 25, 2019 | Roth Capital | Downgrade | Buy | Neutral |
| Feb 14, 2018 | Oppenheimer | Initiated | — | Outperform |
| Dec 19, 2016 | PiperJaffray | Initiated | — | Overweight |
| Sep 16, 2016 | Roth Capital | Initiated | — | Buy |
| Aug 29, 2016 | Janney Capital | Initiated | — | Buy |
| Sep 2, 2015 | H.C. Wainwright | Initiated | — | Buy |
| Jun 18, 2015 | Brean Capital | Maintained | — | Buy |
| Dec 8, 2014 | Aegis Capital | Downgrade | Buy | Hold |
| Jun 12, 2014 | Aegis Capital | Initiated | — | Buy |